Full Name
Boon Cher Goh
Variants
Goh, Boon Cher
Goh B.C.
Goh, B.C.
Goh, B.-C.
 
Main Affiliation
 
 
Email
phcgbc@nus.edu.sg
 
 

Publications

Results 61-80 of 140 (Search time: 0.019 seconds).

Issue DateTitleAuthor(s)
6110-Jul-2018Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: A randomized controlled trialSyn N.L.; Wong A.L.-A. ; Lee S.-C. ; Teoh H.-L. ; Yip J.W.L. ; Seet R.C.S. ; Yeo W.T. ; Kristanto W.; Bee P.-C.; Poon L.M. ; Marban P. ; Wu T.S.; Winther M.D.; Brunham L.R.; Soong R. ; Tai B.-C.; Goh B.-C. 
62Oct-2008Hepatic metastases: In vivo assessment of perfusion parameters at dynamic contrast-enhanced MR imaging with dual-input two- compartment tracer kinetics model1Koh, T.S.; Thng, C.H.; Lee, P.S.; Hartono, S.; Rumpel, H.; Goh, B.C. ; Bisdas, S.
632008Hepatic metastases: In vivo assessment of perfusion parameters at dynamic contrast-enhanced MR imaging with dual-input two- compartment tracer kinetics model1Koh, T.S.; Hartono, S.; Thng, C.H.; Lee, P.S.; Rumpel, H.; Goh, B.C. ; Bisdas, S.
642016High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancerWang, T ; Srivastava, S ; Hartman, M ; Buhari, S.A ; Chan, C.-W ; Iau, P; Khin, L.W ; Wong, A ; Tan, S.-H ; Goh, B.-C ; Lee, S.-C 
52016High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in SingaporeTan, L.S.Y; Fredrik, P; Ker, L; Yu, F.G ; Wang, D.Y ; Goh, B.C ; Loh, K.S ; Lim, C.M 
620-Dec-2021Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancerYadav, Kritika ; Lim, Joline ; Choo, Joan; Ow, Samuel Guan Wei ; Wong, Andrea; Lee, Matilda; Chan, Ching Wan ; Hartman, Mikael ; Lim, Siew Eng; Ngoi, Natalie; Tang, Siau Wei ; Ang, Yvonne; Chan, Gloria; Chong, Wan Qin; Tan, Hon Lyn; Tan, Sing Huang ; Goh, Boon Cher ; Lee, Soo Chin 
72008Influence of UGT1A9 intronic I399C>T polymorphism on SN-38 glucuronidation in Asian cancer patientsSandanaraj, E.; Jada, S.R. ; Shu, X.; Zhou, Q.; Chowbay, B.; Lim, R.; Lee, S.C.; Goh, B.C. ; Zhou, S.
814-Aug-2020Integration of antiangiogenic therapy with cisplatin and gemcitabine chemotherapy in patients with nasopharyngeal carcinoma.Chong, Wan Qin; Lim, Chwee Ming ; Sinha, Arvind Kumar ; Tan, Chee Seng ; Chan, Gloria Hui Jia; Huang, Yiqing; Barr Kumarakulasinghe, Nesaretnam; Sundar, Raghav ; Jeyasekharan, Anand D ; Loh, Woei Shyang ; Tay, Joshua K. ; Yadav, Kritika ; Wang, Lingzhi ; Wong, Andrea L. ; Kong, Li Ren ; Soo, Ross Andrew ; Lau, Jieying Amelia ; Soon, Yu Yang ; Goh, Robby Miguel; Ho, Francis Cho Hao ; Chong, Siew Meng ; Lee, Soo-Chin ; Loh, Kwok Seng ; Tai, Bee Choo ; Lim, Yaw Chyn ; Goh, Boon Cher 
9Mar-2006Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian populationLee, S.-C.; Ng, S.-S.; Oldenburg, J.; Chong, P.-Y. ; Rost, S.; Guo, J.-Y.; Yap, H.-L.; Rankin, S.C.; Khor, H.-B.; Yeo, T.-C.; Ng, K.-S.; Soong, R. ; Goh, B.-C. 
102007Irofulven as first line therapy in recurrent or metastatic gastric cancer: A phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)Yeo, W.; Zee, B.; Ma, B.; Lam, K.C.; Mo, F.K.F.; Ng, E.K.W.; Ho, R.; Chan, A.T.C.; Yeo, W.; Boyer, M.; Clarke, S.; Beale, P.; Chung, H.C.; Roh, J.K.; Rha, S.Y.; Jeung, H.C.; Ong, S.Y.K.; Lim, R.; Soo, R.; Goh, B.C. 
112006Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinomaLee, S.-C.; Soo, R.; Guo, J.-Y.; Goh, B.-C. ; Lim, S.-G. ; Putti, T. ; Soong, R. ; Hsieh, W.-S.; Tao, Q.
12Dec-2017'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signallingOng, Mei S; Cai, Wanpei ; Yuan, Yi; Leong, Hin C ; Tan, Tuan Z ; Mohammad, Asad; You, Ming L; Arfuso, Frank; Goh, Boon C ; Warrier, Sudha; Sethi, Gautam ; Tolwinski, Nicholas S; Lobie, Peter E ; Yap, Celestial T ; Hooi, Shing C ; Huang, Ruby Y ; Kumar, Alan P 
1320-Aug-2016Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast CarcinomaLoo, Ser Yue ; Hirpara, Jayshree L ; Pandey, Vijay ; Tan, Tuan Zea ; Yap, Celestial T ; Lobie, Peter E ; Thiery, Jean Paul ; Goh, Boon Cher ; Pervaiz, Shazib ; Clement, Marie-Veronique ; Kumar, Alan Prem 
142005Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugsZhou, S. ; Chan, S.Y. ; Goh, B.C. ; Chan, E. ; Duan, W. ; Huang, M.; McLeod, H.L.
151-Jul-2015MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell CarcinomaKong, Li Ren ; Chua, Kian Ngiap ; Sim, Wen Jing ; Ng, Hsien Chun ; Bi, Chonglei; Ho, Jingshan ; Nga, Min En ; Pang, Yin Huei ; Ong, Weijie Richard; Soo, Ross Andrew ; Huynh, The Hung ; Chng, Wee Joo ; Thiery, Jean-Paul ; Goh, Boon Cher 
165-Dec-2019MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphomaLi, Boheng ; Yan, Junli ; The, Phyu; Fan, Shuangyi ; Chung, Tae-Hoon; Mustafa, Nurulhuda; Lin, Baohong; Wang, Lingzhi ; Eichhorn, Pieter Johan Adam; Goh, Boon-Cher ; Ng, Siok-Bian ; Kappei, Dennis; Chng, Wee-Joo 
171-Jul-2019Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistanceHirpara, Jayshree ; Eu, Jie Qing ; Tan, Joanna Kia Min; Wong, Andrea L. ; Clement, Marie-Veronique ; Kong, Li Ren ; Ohi, Naoto; Tsunoda, Takeshi; Qu, Jianhua ; Goh, Boon Cher ; Pervaiz, Shazib 
1826-Sep-2018Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancersKumar, R ; Coronel, L; Somalanka, B; Raju, A; Aning, OA; An, O ; Ho, YS; Chen, S; Mak, SY; Hor, PY; Yang, H ; Lakshmanan, M ; Itoh, H; Tan, SY ; Lim, YK ; Wong, APC ; Chew, SH; Huynh, TH ; Goh, BC ; Lim, CY ; Tergaonkar, V ; Cheok, CF 
192004Multidrug resistance protein 4 (MRP4/ABCC4) mediates efflux of bimane-glutathioneBai, J. ; Lai, L.; Tan, T.M.C. ; Yeo, H.C.; Goh, B.C. 
202015Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patientsDai X.; Ahn K.S.; Kim C.; Siveen K.S. ; Ong T.H.; Shanmugam M.K. ; Li F.; Shi J. ; ALAN PREM KUMAR ; Wang L.Z. ; Goh B.C. ; Magae J.; Hui K.M.; Sethi G.